Replies to post #241964 on Biotech Values

[DewDiligence]

ABBV’s #2 executive, Mike Severino, is leaving to become CEO of a biotech startup:

https://www.sec.gov/ix?doc=/Archives/edgar/data/1551152/000110465922045308/tm2212581d1_8k.htm

Severino did a lot of the investor interfacing, and I thought he was a little shady in his characterizations of RVNC's Daxi.